National Center for Complementary & Alternative Medicine; Notice of Closed Meetings, 29702-29703 [E9-14701]
Download as PDF
29702
Federal Register / Vol. 74, No. 119 / Tuesday, June 23, 2009 / Notices
site data will be collected via
questionnaires on the home visit
relationship and a systems partnership
survey.
Respondents: EBHV grantee and key
staff (i.e., evaluators, home visitors and
supervisors), partners, and home
visiting participants.
ANNUAL BURDEN ESTIMATES
Annual
number of
respondents
Instrument
EBHV grantee and key staff-partner interview guide ......................................
EBHV grantee progress report evaluation data ..............................................
EBHV grantee web-based data entry system .................................................
Participant home visiting relationship questionnaire .......................................
Home Visitor home visiting relationship questionnaire ....................................
EBHV grantee-partner systems partnership survey ........................................
Estimated Total Burden Hours: 5,101.
In compliance with the requirements
of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995, the
Administration for Children and
Families is soliciting public comment
on the specific aspects of the
information collection described above.
Copies of the proposed collection of
information can be obtained and
comments may be forwarded by writing
to the Administration for Children and
Families, Office of Planning, Research
and Evaluation, 370 L’Enfant
Promenade, SW., Washington, DC
20447, Attn: OPRE Reports Clearance
Officer. E-mail address:
OPREinfocollection@acf.hhs.gov. All
requests should be identified by the title
of the information collection.
The Department specifically requests
comments on (a) Whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
the quality, utility, and clarity of the
information to be collected; and (d)
ways to minimize the burden of the
collection of information on
respondents, including through the use
of automated collection techniques or
other forms of information technology.
Consideration will be given to
comments and suggestions submitted
within 60 days of this publication.
Dated: June 17, 2009.
Seth F. Chamberlain,
OPRE Reports Clearance Officer.
[FR Doc. E9–14624 Filed 6–22–09; 8:45 am]
BILLING CODE 4184–01–M
VerDate Nov<24>2008
16:15 Jun 22, 2009
Jkt 217001
Number of
responses per
respondents
249
17
17
2,000
2,000
142
Average
burden hour
per response
2
2
12
2
2
2
Estimated
annual burden
hours
1.6
8.00
9.50
0.25
0.25
0.33
797
272
1,938
1,000
1,000
94
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Neurological Disorders and Stroke Special
Emphasis Panel. ARRA Supplement Review
Panel.
Date: June 26, 2009.
Time: 3 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: State Plaza Hotel, 2117 E Street,
NW., Washington, DC 20037.
Contact Person: Ernest W Lyons, PhD,
Scientific Review Administrator, Scientific
Review Branch, NINDS/NIH/DHHS,
Neuroscience Center, 6001 Executive Blvd.,
Suite 3208, MSC 9529, Bethesda, MD 20892–
9529. 301–496–4056. lyonse@ninds.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.853, Clinical Research
Related to Neurological Disorders; 93.854,
Biological Basis Research in the
Neurosciences; 93.701, ARRA Related
Biomedical Research and Research Support
Awards., National Institutes of Health, HHS)
Center for Scientific Review; Amended
Notice of Meeting
Notice is hereby given of a change in
the meeting of the Center for Scientific
Review Special Emphasis Panel, June
29, 2009, 2 p.m. to June 29, 2009, 5
p.m., National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD, 20892
which was published in the Federal
Register on June 11, 2009, 74 FR 27806–
27808.
The meeting time on June 29, 2009
has been changed to 11 a.m. to 12:30
p.m. The meeting date and location
remain the same. The meeting is closed
to the public.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–14694 Filed 6–22–09; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Neurological
Disorders and Stroke; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
PO 00000
Frm 00047
Fmt 4703
Sfmt 4703
Dated: June 17, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–14696 Filed 6–22–09; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Center for Complementary &
Alternative Medicine; Notice of Closed
Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
E:\FR\FM\23JNN1.SGM
23JNN1
Federal Register / Vol. 74, No. 119 / Tuesday, June 23, 2009 / Notices
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Center for
Complementary and Alternative Medicine
Special Emphasis Panel; RFA AT09–002
Translational Tools for Clinical Studies of
CAM Interventions.
Date: July 15, 2009.
Time: 12 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892, (Telephone
Conference Call).
Contact Person: Ray Bramhall, PhD,
Scientific Review Officer, National Center for
Complementary and Alternative Medicine,
6707 Democracy Blvd., Suite 401, Bethesda,
MD 20892, bramhallr@mail.nih.gov.
Name of Committee: National Center for
Complementary and Alternative Medicine
Special Emphasis Panel; Botanical Centers.
Date: August 2–3, 2009.
Time: 5 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Courtyard Marriott Washingtonian
Center, 204 Boardwalk Place, Gaithersburg,
MD 20814.
Contact Person: Martina Schmidt, PhD,
Scientific Review Officer, Office of Scientific
Review, National Center for Complementary
& Alternative Medicine, NIH, 6707
Democracy Blvd., Suite 401, Bethesda, MD
20892, 301–594–3456,
schmidma@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.213, Research and Training
in Complementary and Alternative Medicine,
National Institutes of Health, HHS)
29703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): American
Recovery and Reinvestment Act
(ARRA)-Section 317 Immunization
Program: Strengthening the Evidence
Base Measuring Effectiveness of Two
Dose of Varicella Vaccine, Funding
Opportunity Announcement (FOA)
IP04–11601ARRA09, Initial Review
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Translating
Research To Protect Health Through
Health Promotion, Prevention, and
Preparedness, Panel D, Funding
Opportunity Announcement (FOA)
CD09–001, Initial Review
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the aforementioned meeting.
Time and Date: 12 p.m.–2 p.m., July 28,
2009 (Closed).
Place: Teleconference.
Status: The meeting will be closed to the
public in accordance with provisions set
forth in Section 552b(c) (4) and (6), Title 5
U.S.C., and the Determination of the Director,
Management Analysis and Services Office,
CDC, pursuant to Public Law 92–463.
Matters to be Discussed: The meeting will
include the initial review, discussion, and
evaluation of ‘‘ARRA-Section 317
Immunization Program: Strengthening the
Evidence Base Measuring Effectiveness of
Two Dose of Varicella Vaccine, FOA IP04–
11601ARRA09.’’
For More Information Contact: Wendy
Carr, PhD, CDC, 1600 Clifton Road, NE.,
Mailstop E60, Atlanta, GA 30333, Telephone:
(404) 498–2276.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both CDC and the Agency for Toxic
Substances and Disease Registry.
Dated: June 17, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–14701 Filed 6–22–09; 8:45 am]
Dated: June 12, 2009.
Elaine L. Baker,
Director, Management Analysis and Services
Office Centers for Disease Control and
Prevention.
[FR Doc. E9–14664 Filed 6–22–09; 8:45 am]
BILLING CODE 4140–01–P
BILLING CODE 4163–18–P
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the aforementioned meeting:
Time and Date: 9 a.m.–5 p.m., July 21,
2009 (Closed). 9 a.m.–1 p.m., July 22, 2009
(Closed).
Place: W Hotel, Midtown, 188 14th Street,
NE., Atlanta, Georgia 30361, Telephone:
(404) 892–6000.
Status: The meeting will be closed to the
public in accordance with provisions set
forth in section 552b(c)(4) and (6), Title 5
U.S.C., and the Determination of the Director,
Management Analysis and Services Office,
CDC, pursuant to Public Law 92–463.
Matters To Be Discussed: The meeting will
include the initial review, discussion, and
evaluation of ‘‘Translating Research to
Protect Health through Health Promotion,
Prevention, and Preparedness, Panel D, FOA
CD09–001, initial review.’’
For More Information Contact: Christine J.
Morrison, PhD, Scientific Review
Administrator, CDC, 1600 Clifton Road, NE.,
Mailstop D72, Atlanta, GA 30333, Telephone
(404) 639–3098.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both CDC and the Agency for Toxic
Substances and Disease Registry.
Dated: June 15, 2009.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. E9–14659 Filed 6–22–09; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
Notice of Hearing: Reconsideration of
Disapproval of Washington State Plan
Amendment (SPA) 08–019
AGENCY: Centers for Medicare &
Medicaid Services (CMS), HHS.
ACTION: Notice of Hearing.
VerDate Nov<24>2008
16:15 Jun 22, 2009
Jkt 217001
PO 00000
Frm 00048
Fmt 4703
Sfmt 4703
E:\FR\FM\23JNN1.SGM
23JNN1
Agencies
[Federal Register Volume 74, Number 119 (Tuesday, June 23, 2009)]
[Notices]
[Pages 29702-29703]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-14701]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Center for Complementary & Alternative Medicine; Notice
of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
[[Page 29703]]
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Center for Complementary and
Alternative Medicine Special Emphasis Panel; RFA AT09-002
Translational Tools for Clinical Studies of CAM Interventions.
Date: July 15, 2009.
Time: 12 p.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Two Democracy Plaza, 6707
Democracy Boulevard, Bethesda, MD 20892, (Telephone Conference
Call).
Contact Person: Ray Bramhall, PhD, Scientific Review Officer,
National Center for Complementary and Alternative Medicine, 6707
Democracy Blvd., Suite 401, Bethesda, MD 20892,
bramhallr@mail.nih.gov.
Name of Committee: National Center for Complementary and
Alternative Medicine Special Emphasis Panel; Botanical Centers.
Date: August 2-3, 2009.
Time: 5 p.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Courtyard Marriott Washingtonian Center, 204 Boardwalk
Place, Gaithersburg, MD 20814.
Contact Person: Martina Schmidt, PhD, Scientific Review Officer,
Office of Scientific Review, National Center for Complementary &
Alternative Medicine, NIH, 6707 Democracy Blvd., Suite 401,
Bethesda, MD 20892, 301-594-3456, schmidma@mail.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.213,
Research and Training in Complementary and Alternative Medicine,
National Institutes of Health, HHS)
Dated: June 17, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E9-14701 Filed 6-22-09; 8:45 am]
BILLING CODE 4140-01-P